Daily Systematic Metro EPaper News National and International Political Sports Religion
Health

Study Suggests Shingles Vaccine May Be Linked to Lower Dementia Risk

Study Suggests Shingles Vaccine May Be Linked to Lower Dementia Risk

A recent large-scale study has found a possible association between the shingles vaccine Shingrix and a reduced risk of dementia in older adults.

Researchers, including a team from Brown University in the United States, analyzed medical data from more than 500,000 individuals admitted to nursing facilities between 2017 and 2022.

The study focused on this population to better observe health outcomes in older adults who are at higher risk of both shingles and dementia.

Key Findings

According to the results, individuals who received the Shingrix vaccine within 12 months of admission showed a lower rate of dementia over a four-year follow-up period compared to those who did not receive the vaccine.

The findings indicated a noticeable difference in outcomes between the two groups, suggesting a potential association between vaccination and reduced dementia risk.

Background on Shingles Vaccines

Shingrix is a newer shingles vaccine that has replaced earlier formulations such as Zostavax in many regions. It is considered more effective in preventing shingles and provides longer-lasting protection.

Previous research has also explored a possible link between shingles vaccination and brain health, including potential neuroprotective effects, though the exact biological mechanisms are still being studied.

Researchers’ Perspective

Scientists involved in the study described the findings as part of a growing body of research exploring the broader health effects of vaccines beyond their primary purpose.

They emphasized that while the results show an association, further research is needed to understand whether the vaccine directly contributes to reduced dementia risk or whether other factors may also play a role.

Conclusion

The study adds to ongoing scientific interest in the relationship between infectious disease prevention and long-term brain health. Researchers continue to explore how vaccines and immune responses may influence neurological outcomes in aging populations.

Related posts

Pakistan Reports Decline in Environmental Poliovirus Detection During First Half of 2026

Editor

Lahore to Get Three New Specialized Hospitals Under Medical City Project The Punjab government has announced plans to establish three new major hospitals in Lahore as part of the Nawaz Sharif Medical City project. The hospitals will be developed in LDA City, where 216 acres of land have been allocated for the project. Three Hospitals Planned One of the projects is the Maryam Nawaz Institute of Pediatric Health Sciences, which will have 352 beds. The pediatric hospital is expected to cost around Rs8 billion and will focus on healthcare services for children. Another facility will be the Nawaz Sharif Institute of Burn, Plastic Surgery and Trauma Centre. The centre will have 175 beds and is estimated to cost approximately Rs6.15 billion. Genetic Blood Diseases Institute The third facility will be the Nawaz Sharif Institute of Genetic Blood Diseases. The institute is planned at the same location and has an estimated development cost of Rs10 billion. The facility is expected to focus on the diagnosis and treatment of genetic blood-related disorders. IDAP Assigned Construction Work The construction of all three hospitals has been assigned to the Infrastructure Development Authority of Punjab (IDAP). The projects are part of the broader Nawaz Sharif Medical City initiative planned for LDA City and are intended to expand specialized healthcare facilities in Lahore.

Editor

Global Cancer Report Highlights Rising Cases and Calls for Stronger Prevention Efforts

Editor

Leave a Comment